Osaic Holdings
GYRE icon

Osaic Holdings’s Gyre Therapeutics GYRE Stock Holding History

Osaic Holdings’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288 Buy
44
+6
+16% +$41 ﹤0.01% 7727
2026
Q1 		$265 Hold
38
– – ﹤0.01% 7523
2025
Q4 		$268 Hold
38
– – ﹤0.01% 7539
2025
Q3 		$283 Hold
38
– – ﹤0.01% 7647
2025
Q2 		$279 Buy
38
+27
+245% +$236 ﹤0.01% 7459
2025
Q1 		$85 Sell
11
-30
-73% -$329 ﹤0.01% 7249
2024
Q4 		$496 Sell
41
-400
-91% -$5.12K ﹤0.01% 7023
2024
Q3 		$5.53K Sell
441
-200
-31% -$2.58K ﹤0.01% 6150
2024
Q2 		$7.65K Buy
641
+627
+4,479% +$8.6K ﹤0.01% 5947
2024
Q1 		$245 Hold
14
– – ﹤0.01% 6942
2023
Q4 		$360 Sell
14
-12
-46% -$170 ﹤0.01% 6940
2023
Q3 		$188 Buy
26
+12
+86% +$80 ﹤0.01% 7160
2023
Q2 		$76 Hold
14
– – ﹤0.01% 7307
2023
Q1 		$45 Sell
14
-15
-52% -$57 ﹤0.01% 7383
2022
Q4 		$113 Buy
+29
New +$118 ﹤0.01% 7116

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's GYRE Position: Q2 2026 in Review

Osaic Holdings increased its Gyre Therapeutics (GYRE) stake by 16% in Q2 2026, buying an estimated $41 and bringing the position to 44 shares worth $288. The position accounts for ﹤0.01% of the portfolio, ranked #7727.

Osaic Holdings first reported a position in GYRE in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.65K in Q2 2024. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Osaic Holdings held 44 shares of Gyre Therapeutics worth $288 as of Q2 2026.
  • Osaic Holdings bought 6 Gyre Therapeutics shares in Q2 2026, an estimated $41.
  • Gyre Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7727 holding.
  • Osaic Holdings first reported a position in Gyre Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • Osaic Holdings's Gyre Therapeutics position peaked at $7.65K in Q2 2024.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.